Quoin Pharmaceuticals Ltd Stock Price To Earning
| QNRX Stock | USD 6.70 0.12 1.76% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Quoin Pharmaceuticals' long-term financial health and intrinsic value.
Quoin | Price To Earning | Build AI portfolio with Quoin Stock |
Quoin Pharmaceuticals Ltd Company Price To Earning Analysis
Quoin Pharmaceuticals' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Quoin Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for Quoin Pharmaceuticals is extremely important. It helps to project a fair market value of Quoin Stock properly, considering its historical fundamentals such as Price To Earning. Since Quoin Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Quoin Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Quoin Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Quoin Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, Quoin Pharmaceuticals Ltd has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earning for all United States stocks is 100.0% higher than that of the company.
Quoin Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Quoin Pharmaceuticals from analyzing Quoin Pharmaceuticals' financial statements. These drivers represent accounts that assess Quoin Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Quoin Pharmaceuticals' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 13.6M | 4.7M | 6.9M | 4.4M | 87.2K | 82.8K | |
| Enterprise Value | 8.8M | (210.7K) | 4.0M | 2.0M | (3.5M) | (3.4M) |
Quoin Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Quoin Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Quoin Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Quoin Fundamentals
| Return On Equity | -1.39 | ||||
| Return On Asset | -0.47 | ||||
| Current Valuation | (7.61 M) | ||||
| Shares Outstanding | 588.17 K | ||||
| Shares Owned By Insiders | 7.07 % | ||||
| Shares Owned By Institutions | 6.85 % | ||||
| Number Of Shares Shorted | 9.15 K | ||||
| Price To Book | 0.68 X | ||||
| EBITDA | (8.9 M) | ||||
| Net Income | (8.96 B) | ||||
| Cash And Equivalents | 2.69 M | ||||
| Cash Per Share | 0.56 X | ||||
| Total Debt | 6.5 M | ||||
| Debt To Equity | 0.47 % | ||||
| Current Ratio | 0.96 X | ||||
| Book Value Per Share | 10.07 X | ||||
| Cash Flow From Operations | (7.86 B) | ||||
| Short Ratio | 1.28 X | ||||
| Earnings Per Share | (33.99) X | ||||
| Target Price | 150.0 | ||||
| Beta | 1.82 | ||||
| Market Capitalization | 3.94 M | ||||
| Total Asset | 15.71 M | ||||
| Retained Earnings | (55.17 B) | ||||
| Working Capital | 10.75 M | ||||
| Net Asset | 15.71 M |
About Quoin Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Quoin Pharmaceuticals Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quoin Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quoin Pharmaceuticals Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.